Study of Visual Mecanisms Involved in Face Recognition

NCT ID: NCT06851923

Last Updated: 2025-02-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-01

Study Completion Date

2030-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Since the 19th century, perception has been regarded as an inferential process in which sensory input is compared with prior knowledge, namely the internalised representation of the visual environment. This notion is central to the understanding of everyday perception and cognition in general, and is attracting much attention in various areas of psychology and cognitive neuroscience. However, it is unclear whether and how the primary visual refinement that is thought to underlie the convergence of bottom-up inputs with top-down prior knowledge applies to the processing of meaningful stimuli in our everyday lives. The investigators have shown that human face processing mechanisms are shaped by prior knowledge that the horizontal range of face information conveys the richest and most reliable cues. Furthermore, investigators' previous data suggest that the primary visual cortex is recruited during the progressive refinement of face representation. Using very high field neuroimaging, the present project proposes to follow the neural mechanisms underlying the cortical refinement of horizontal information in human face processing, and to study their contribution to behaviour.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Young Healthy Adults Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study of the visual mechanisms involved in face perception

Group Type EXPERIMENTAL

3Tesla magnetic resonance imaging of the healthy human visual system

Intervention Type OTHER

The present project presents a series of monocentric MRI studies carried out on healthy adult human volunteers. All neuroimaging will be performed at the Cliniques Universitaires Saint-Luc (CUSL, IRM de recherche). Participants will not directly benefit from their participation. All studies will manipulate the visual properties of the experimental stimuli in a within-subject way, and therefore do not rely on any participation group assignation/randomization method. The duration of studies will vary between 3h to 6h, i.e., from 2 to 4x1h30 3Tesla magnetic resonance imaging sessions depending on the experimental design.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

3Tesla magnetic resonance imaging of the healthy human visual system

The present project presents a series of monocentric MRI studies carried out on healthy adult human volunteers. All neuroimaging will be performed at the Cliniques Universitaires Saint-Luc (CUSL, IRM de recherche). Participants will not directly benefit from their participation. All studies will manipulate the visual properties of the experimental stimuli in a within-subject way, and therefore do not rely on any participation group assignation/randomization method. The duration of studies will vary between 3h to 6h, i.e., from 2 to 4x1h30 3Tesla magnetic resonance imaging sessions depending on the experimental design.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be between 18 and 50 years old,
* have normal eyesight or eyesight corrected with contact lenses,
* Have no neurological disorder,
* Not have had a skull fracture or head surgery,
* Have no chronic progressive illness or mental deficiency,
* Have no metal parts in their body (dental braces or pins, metal plates, pacemakers, implanted prostheses, etc.),
* Have no tattoos containing metallic particles or implanted jewellery (e.g. piercings) that cannot be removed,
* Not to have worked with metals,
* Do not take any medicines or substances that may affect brain function (e.g. drugs, energy drinks, alcohol),
* Not to be pregnant or breastfeeding.
* Do not be claustrophobic.

Exclusion Criteria

Participants presenting a counter-indication (responding yes to one of the questions of the screening questionnaire, see annex 2) to participate will be excluded from participation.

Participants will be screened to ascertain they do not present any of these counter-indications to the participation to the MRI measurement. We will exclude people with these characteristics:

* Be younger than 18 or older than 50 years old,
* have poor eyesight,
* Have neurological disorder,
* have had a skull fracture or head surgery,
* Have a chronic progressive illness or mental deficiency,
* Have metal parts in their body (dental braces or pins, metal plates, pacemakers, implanted prostheses, etc.),
* Have tattoos containing metallic particles or implanted jewellery (e.g. piercings) that cannot be removed,
* have worked with metals,
* take medicines or substances that may affect brain function (e.g. drugs, energy drinks, alcohol),
* pregnant or breastfeeding.
* claustrophobic.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université Catholique de Louvain

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Valerie Goffaux, PhD

Role: STUDY_DIRECTOR

Université Catholique de Louvain

Mrittika Dey, Master

Role: PRINCIPAL_INVESTIGATOR

Université Catholique de Louvain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Valerie Goffaux, PhD

Role: CONTACT

003210473877

Laurence Dricot, PhD

Role: CONTACT

0032 479 230 206

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HUMVIS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Attention and Visual Perception
NCT00111293 COMPLETED
Gender in Face-Voice Integration
NCT03058133 COMPLETED NA